| |
| |
|
| Insider
Information: |
Blumenkranz Mark S. |
| Relationship: |
|
| City: |
Menlo Park |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
5 |
|
| Direct
Shares |
553,683 |
|
|
Indirect Shares
|
201,323 |
|
|
| Direct
Value |
$4,126,835 |
|
|
|
Indirect Value
|
$1,252,329 |
|
|
| Total
Shares |
755,006 |
|
|
| Total
Value |
$5,379,165 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Adverum Biotechnologies, Inc |
ADVM |
Director |
2016-02-12 |
531,322 |
2016-02-12 |
31,593 |
Premium* |
|
|
Presbia Plc |
LENS |
Director |
2015-03-16 |
9,270 |
2015-03-16 |
0 |
Premium* |
|
|
Iveric Bio Inc |
ISEE |
Director |
2023-07-11 |
0 |
2021-07-15 |
0 |
Premium* |
|
|
Kala Pharmaceuticals, Inc. |
KALA |
|
2024-06-11 |
13,091 |
2024-06-11 |
169,730 |
Premium* |
|
|
1life Healthcare Inc |
ONEM |
|
2023-02-22 |
0 |
2022-06-02 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
37 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 2
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ADVM |
Adverum Biotechnologies, ... |
Director |
– • – |
2014-07-30 |
3/A |
IO |
$0.00 |
$0 |
D/D |
0 |
700,000 |
|
- |
|
| ADVM |
Adverum Biotechnologies, ... |
Director |
– • – |
2014-08-05 |
4 |
OE |
$0.15 |
$3,750 |
D/D |
25,000 |
725,000 |
0 |
- |
|
| ADVM |
Adverum Biotechnologies, ... |
Director |
– • – |
2014-08-05 |
4 |
A |
$0.00 |
$0 |
D/D |
20,989 |
745,989 |
0 |
- |
|
| ADVM |
Adverum Biotechnologies, ... |
Director |
– • – |
2014-08-05 |
4 |
A |
$0.00 |
$0 |
I/I |
37,593 |
12,531 |
0 |
- |
|
| ADVM |
Adverum Biotechnologies, ... |
Director |
– • – |
2015-01-13 |
4 |
S |
$55.46 |
$5,546,000 |
D/D |
(100,000) |
645,989 |
0 |
- |
|
| LENS |
Presbia Plc |
Director |
– • – |
2015-03-16 |
4 |
A |
$0.00 |
$0 |
D/D |
9,270 |
9,270 |
0 |
- |
|
| ADVM |
Adverum Biotechnologies, ... |
Director |
– • – |
2015-04-07 |
4 |
AS |
$38.59 |
$868,560 |
D/D |
(22,500) |
623,489 |
0 |
- |
|
| ADVM |
Adverum Biotechnologies, ... |
Director |
– • – |
2015-04-07 |
4 |
AS |
$38.59 |
$115,808 |
I/I |
(3,000) |
11,531 |
0 |
- |
|
| ADVM |
Adverum Biotechnologies, ... |
Director |
– • – |
2015-04-08 |
4 |
AS |
$39.94 |
$99,841 |
D/D |
(2,500) |
620,989 |
0 |
- |
|
| ADVM |
Adverum Biotechnologies, ... |
Director |
– • – |
2015-04-16 |
4 |
AS |
$41.59 |
$1,039,753 |
D/D |
(25,000) |
595,989 |
0 |
- |
|
| ADVM |
Adverum Biotechnologies, ... |
Director |
– • – |
2015-04-21 |
4 |
A |
$0.00 |
$0 |
D/D |
2,000 |
597,989 |
0 |
- |
|
| ADVM |
Adverum Biotechnologies, ... |
Director |
– • – |
2015-05-01 |
4 |
AS |
$32.37 |
$647,306 |
D/D |
(20,000) |
577,989 |
0 |
- |
|
| ADVM |
Adverum Biotechnologies, ... |
Director |
– • – |
2015-05-11 |
4 |
AS |
$34.91 |
$62,323 |
D/D |
(1,785) |
576,204 |
0 |
- |
|
| ADVM |
Adverum Biotechnologies, ... |
Director |
– • – |
2015-05-13 |
4 |
AS |
$34.94 |
$24,984 |
D/D |
(715) |
575,489 |
0 |
- |
|
| ADVM |
Adverum Biotechnologies, ... |
Director |
– • – |
2015-05-15 |
4 |
AS |
$35.36 |
$798,553 |
D/D |
(22,500) |
552,989 |
0 |
- |
|
| ADVM |
Adverum Biotechnologies, ... |
Director |
– • – |
2015-05-19 |
4 |
AS |
$36.91 |
$110,734 |
I/I |
(3,000) |
10,531 |
0 |
- |
|
| ADVM |
Adverum Biotechnologies, ... |
Director |
– • – |
2015-06-05 |
4 |
AS |
$40.08 |
$200,414 |
D/D |
(5,000) |
547,989 |
0 |
- |
|
| ADVM |
Adverum Biotechnologies, ... |
Director |
– • – |
2015-06-09 |
4 |
AS |
$35.52 |
$804,328 |
D/D |
(22,500) |
525,489 |
0 |
- |
|
| ADVM |
Adverum Biotechnologies, ... |
Director |
– • – |
2015-06-10 |
4 |
AS |
$39.91 |
$23,948 |
D/D |
(600) |
524,889 |
0 |
- |
|
| ADVM |
Adverum Biotechnologies, ... |
Director |
– • – |
2015-06-11 |
4 |
AS |
$39.97 |
$75,939 |
D/D |
(1,900) |
522,989 |
0 |
- |
|
| ADVM |
Adverum Biotechnologies, ... |
Director |
– • – |
2016-02-12 |
4 |
A |
$0.00 |
$0 |
D/D |
8,333 |
531,322 |
0 |
- |
|
| ISEE |
Iveric Bio Inc |
Director |
– • – |
2021-07-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,000 |
5,000 |
0 |
- |
|
| KALA |
Kala Pharmaceuticals, Inc... |
|
– • – |
2021-11-15 |
4 |
A |
$0.00 |
$0 |
D/D |
157,765 |
157,765 |
0 |
- |
|
| KALA |
Kala Pharmaceuticals, Inc... |
|
– • – |
2021-11-15 |
4 |
A |
$0.00 |
$0 |
I/I |
5,183,355 |
38,965 |
0 |
- |
|
| ISEE |
Iveric Bio Inc |
Director |
– • – |
2022-05-11 |
4 |
OE |
$0.00 |
$0 |
D/D |
7,500 |
12,500 |
0 |
- |
|
37 Records found
|
|
Page 1 of 2 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
